Hapvida Raises R$2.7 billion in Primary and Secondary Offerings

Posted Friday, May 7th 2021
Hapvida Raises R$2.7 billion in Primary and Secondary Offerings

On April 11, leading healthcare provider Hapvida's board of directors approved a public share offering of 135 million ordinary shares with the possibility of an additional secondary offering of 45 million shares, set to occur in Brazil and the United States, according to its filing before the Brazilian Securities and Exchange Commission (CVM)

 

On April 21, the deal, which was captained by BTG Pactual, alongside Bank of America, Merril Lynch, Itaú BBA, XP Investimentos, Credit Suisse and Citigroup Global Markets Brasil, sucessfully raised R$2.7 billion with Hapvida's shares priced at R$15.  

 

According to Hapvida, the funds will now be invested in improving its existing operations, as well as finance ongoing and future M&A deals.